Myopia Control: Ortho-K vs. Low-Dose Atropine
Wednesday, November 19 2025 | 08 h 41 min | Vision Science
Based on: JAMA Ophthalmology, 2025 – Randomized Clinical Trial At a Glance Population: Children & adolescents with progressing...
Read More
Two-Year Clinical Results Reinforce Long-Term Effectiveness of MyoPro® Lens
Tuesday, November 11 2025 | 08 h 05 min | News
Newly published two-year clinical data in Investigative Ophthalmology & Visual Science (IOVS) confirm that the MyoPro® Defocus Lens continues...
Read More
EssilorLuxottica Invests $1.5M CAD in Canada’s Optometry Schools to Fuel Research and Train the Next Generation of Eye Care Leaders
Monday, November 3 2025 | 15 h 32 min | News
EssilorLuxottica announced a multi-year pledge of more than $15M CAD to The Université de Montréal – École d’Optométrie and the University...
Read More
Rodenstock MyCon™2: A New Geneation of Children’s Lenses Created to Control Myopia
Monday, October 20 2025 | 12 h 10 min | News
With MyCon™ 2, Rodenstock takes four individual wearing parameters into account when calculating the lens (PD, CVD, PT & FFA) This provides a...
Read More
Academy ’25: New Data Strengthens Evidence for DOT™ Myopia Control Lenses
Monday, October 6 2025 | 16 h 16 min | News
SightGlass Vision presented new data at the American Academy of Optometry 2025 Annual Meeting in Boston showing the continued effectiveness of its...
Read More
